Vistin Pharma ASA (VISTN) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.010x

Based on the latest financial reports, Vistin Pharma ASA (VISTN) has a cash flow conversion efficiency ratio of -0.010x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-3.67 Million ≈ $-386.40K USD) by net assets (Nkr350.31 Million ≈ $36.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Vistin Pharma ASA (VISTN) market capitalisation for the company's overall valuation and market capitalisation.

Vistin Pharma ASA - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Vistin Pharma ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vistin Pharma ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vistin Pharma ASA ranked by their cash flow conversion efficiency. Explore Vistin Pharma ASA earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Yirendai Ltd NYSE:YRD	-0.001x
Townsquare Media Inc NYSE:TSQ	-0.040x
Katmerciler Arac Ustu Ekipman Sanayi ve Ticaret AS IS:KATMR	-0.038x
Concorde International Group Ltd Class A Ordinary Shares NASDAQ:CIGL	-0.157x
KUYA SILVER CORP. F:6MR1	-0.023x
IFB Agro Industries Limited NSE:IFBAGRO	-0.018x
Hasen-Immobilien AG STU:ABHA	0.010x
Banco Santander Río S.A BA:BRIO	-0.322x

Annual Cash Flow Conversion Efficiency for Vistin Pharma ASA (2016–2025)

The table below shows the annual cash flow conversion efficiency of Vistin Pharma ASA from 2016 to 2025. View current stock price of Vistin Pharma ASA for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Nkr328.81 Million ≈ $34.60 Million	Nkr78.04 Million ≈ $8.21 Million	0.237x	-31.89%
2024-12-31	Nkr309.53 Million ≈ $32.57 Million	Nkr107.86 Million ≈ $11.35 Million	0.348x	+24.15%
2023-12-31	Nkr322.77 Million ≈ $33.96 Million	Nkr90.59 Million ≈ $9.53 Million	0.281x	+964.87%
2022-12-31	Nkr273.26 Million ≈ $28.76 Million	Nkr-8.87 Million ≈ $-933.17K	-0.032x	-165.44%
2021-12-31	Nkr275.89 Million ≈ $29.03 Million	Nkr13.68 Million ≈ $1.44 Million	0.050x	+109.27%
2020-12-31	Nkr272.40 Million ≈ $28.66 Million	Nkr-145.73 Million ≈ $-15.34 Million	-0.535x	-1267.99%
2019-12-31	Nkr413.40 Million ≈ $43.50 Million	Nkr18.93 Million ≈ $1.99 Million	0.046x	+140.47%
2018-12-31	Nkr348.85 Million ≈ $36.71 Million	Nkr-39.48 Million ≈ $-4.15 Million	-0.113x	-243.02%
2017-12-31	Nkr120.16 Million ≈ $12.64 Million	Nkr9.51 Million ≈ $1.00 Million	0.079x	-72.57%
2016-12-31	Nkr186.61 Million ≈ $19.64 Million	Nkr53.84 Million ≈ $5.67 Million	0.288x	--

About Vistin Pharma ASA

OL:VISTN Norway Drug Manufacturers - Specialty & Generic

Market Cap

$87.26 Million

Nkr829.24 Million NOK

Market Cap Rank

#19780 Global

#176 in Norway

Share Price

Nkr18.70

Change (1 day)

-1.58%

52-Week Range

Nkr18.70 - Nkr23.70

All Time High

Nkr28.06